|
1
|
El-Ageery SM and Al-Hazmi SS:
Microbiological and molecular detection of VIM-1 metallo beta
lactamase-producing Acinetobacter baumannii. Eur Rev Med
Pharmacol Sci. 18:965–970. 2014.PubMed/NCBI
|
|
2
|
El-Ageery SM, Abo-Shadi MA, Alghaithy AA,
Ahmad MA, Alsharif NH and Alharbi SA: Epidemiological investigation
of nosocomial infection with multidrug-resistant Acinetobacter
baumannii. Eur Rev Med Pharmacol Sci. 16:1834–1839.
2012.PubMed/NCBI
|
|
3
|
López-Rojas R, Docobo-Pérez F,
Pachón-Ibáñez ME, de la Torre BG, Fernández-Reyes M, March C,
Bengoechea JA, Andreu D, Rivas L and Pachón J: Efficacy of cecropin
A-melittin peptides on a sepsis model of infection by pan-resistant
Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis.
30:1391–1398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shao BB and Feng HB: Successful treatment
of pan-resistant Acinetobacter baumannii infection of the
lung with tigecycline: a report of one case. Zhonghua Wei Zhong
Bing Ji Jiu Yi Xue. 25:6362013.(In Chinese). PubMed/NCBI
|
|
5
|
Magiorakos AP, Srinvasan A, Carey RB,
Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter
G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens
MJ, Vatopoulos A, Weber JT and Monnet DL: Multidrug resistant
extensively drug Resistant and paddrug-resistant bacteria: an
international expert proptsal for interim standard definitions for
acquired resistance. Clin Microbiol Infect. 18:268–281. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Doi Y, Onuoha EO, Adams-Haduch JM, Pakstis
DL, McGaha TL, Werner CA, Parker BN, Brooks MM, Shutt KA, Pasculle
AW, et al: Screening for Acinetobacter baumannii
colonization by use of sponges. J Clin Microbiol. 49:154–158. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spellberg B and Talbot G: Recommended
design features of future clinical trials of antibacterial agents
for hospital-acquired bacterial pneumonia and ventilator-associated
bacterial pneumonia. Clin Infect Dis. 51(Suppl 1): S150–S170, D.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tekçe AY, Erbay A, Çabadak H, Yağcı S,
Karabiber N and Şen S: Pan-resistant Acinetobacter baumannii
mediastinitis treated successfully with tigecycline: a case report.
Surg Infect (Larchmt). 12:141–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Antunes LC, Imperi F, Minandri F and Visca
P: In vitro and in vivo antimicrobial activities of gallium nitrate
against multidrug-resistant Acinetobacter baumannii.
Antimicrob Agents Chemother. 56:5961–5970. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Telang NV, Satpute MG, Dhakephalkar PK,
Niphadkar KB and Joshi SG: Fulminating septicemia due to persistent
pan-resistant community-acquired metallo-β-lactamase
(IMP-1)-positive Acinetobacter baumannii. Indian J Pathol
Microbiol. 54:180–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vila-Farres X, de la Maria Garcia C,
López-Rojas R, Pachón J, Giralt E and Vila J: In vitro activity of
several antimicrobial peptides against colistin-susceptible and
colistin-resistant Acinetobacter baumannii. Clin Microbiol
Infect. 18:383–387. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Prata-Rocha ML, Gontijo-Filho PP and Melo
GB: Factors influencing survival in patients with
multidrug-resistant Acinetobacter baumannii infection. Braz
J Infect Dis. 16:237–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McConnell MJ, Rumbo C, Bou G and Pachón J:
Outer membrane vesicles as an acellular vaccine against
Acinetobacter baumannii. Vaccine. 29:5705–5710. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Le Hello S, Falcot V, Lacassin F, Mikulski
M and Baumann F: Risk factors for carbapenem-resistant
Acinetobacter baumannii infections at a tertiary care
hospital in New Caledonia, South Pacific. Scand J Infect Dis.
42:821–826. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun SM, Wang YY, Yao CJ, Li HL, Yu F,
Zhang YL, Zhou H and Wang NP: Clinical characteristics and therapy
of pan-drug resistant Acinetobacter baumannii infection. Nan
Fang Yi Ke Da Xue Xue Bao. 30:2351–2353, 2359. 2010.(In Chinese).
PubMed/NCBI
|
|
16
|
Principe L, D'Arezzo S, Capone A,
Petrosillo N and Visca P: In vitro activity of tigecycline in
combination with various antimicrobials against multidrug resistant
Acinetobacter baumannii. Ann Clin Microbiol Antimicrob.
8:182009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lü Y, Li Y, Xue F, Zhang XZ, Hu YJ, Jin
YF, Chu YZ, Hu ZD, Zhao JH, Pan SY, et al: Analysis of resistance
tendency of bloodstream-infecting pathogens in China. Zhonghua Jie
He He Hu Xi Za Zhi. 36:411–419. 2013.(In Chinese). PubMed/NCBI
|
|
18
|
Taccone FS, Rodriguez-Villalobos H, De
Backer D, De Moor V, Deviere J, Vincent JL and Jacobs F: Successful
treatment of septic shock due to pan-resistant Acinetobacter
baumannii using combined antimicrobial therapy including
tigecycline. Eur J Clin Microbiol Infect Dis. 25:257–260. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Navon-Venezia S, Ben-Ami R and Carmeli Y:
Update on Pseudomonas aeruginosa and Acinetobacter baumannii
infections in the healthcare setting. Curr Opin Infect Dis.
18:306–313. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ozdem B, Gürelik FC, Celikbilek N, Balıkçı
H and Açıkgöz ZC: Antibiotic resistance profiles of Acinetobacter
species isolated from several clinical samples between 2007–2010.
Mikrobiyol Bul. 45:526–534. 2011.(In Turkish). PubMed/NCBI
|
|
21
|
Kulkova N, Babalova M, Sokolova J and
Krcmery V: First report of New Delhi
metallo-β-lactamase-1-producing strains in Slovakia. Microb Drug
Resist. 21:117–120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fica CA, Céspedes JI, Gompertz GM, Jalón
VM, Sakurada ZA and Sáez LE: Intravenous colistin in the treatment
of infections due to pan-resistant Gram negative bacilli. Rev
Chilena Infectol. 24:360–367. 2007.(In Spanish). PubMed/NCBI
|
|
23
|
Marimuthu K, Gunaselvam P, Rahman Aminur
M, Xavier R, Arockiaraj J, Subramanian S, Yusoff FM and Arshad A:
Antibacterial activity of ovary extract from sea urchin Diadema
setosum. Eur Rev Med Pharmacol Sci. 19:1895–1899. 2015.PubMed/NCBI
|
|
24
|
Karakoc C, Tekin R, Yeşilbağ Z and Cagatay
A: Risk factors for mortality in patients with nosocomial
Gram-negative rod bacteremia. Eur Rev Med Pharmacol Sci.
17:951–957. 2013.PubMed/NCBI
|
|
25
|
Gao Z, Xing H, Sun H and Li H: Experiment
study on the pathogenicity of Staphylococcus aureus in
laboratory mice. Chin J Comp Med. 13:87–89. 2003.
|
